Baseline Characteristics in Patients with Atopic Dermatitis from the North American Prospective Observational Study of Lebrikizumab (ADjoy). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s734, 2026. DOI: 10.25251/djee0862. Disponível em: https://skin.dermsquared.com/skin/article/view/4054. Acesso em: 29 apr. 2026.